"May Contain" Allergen Labels Are Unregulated and Force Families to Guess

Precautionary allergen labels like "may contain traces of peanuts" or "manufactured in a facility that processes tree nuts" are entirely voluntary in the United States. The FDA does not regulate, define, or verify these statements. This means two identical-looking products on the same shelf may carry different warnings not because one is safer than the other, but because one manufacturer's legal team is more cautious. A 2020 study by researchers at Northwestern University found that up to 40% of products with no precautionary label actually contained detectable levels of undeclared allergens. The consequence for the 32 million Americans with food allergies is a daily guessing game at the grocery store. Families must decide: do we trust labels that are essentially unregulated marketing copy, or do we avoid every product with any precautionary statement and limit our diet to a handful of "safe" brands? Most allergists advise the latter, which eliminates large portions of the grocery store. This is not a minor inconvenience; it means parents of allergic children spend an average of 3-5 extra hours per week on meal planning and grocery shopping, according to a 2019 survey by the Asthma and Allergy Foundation of America. The financial impact is significant. Allergen-free substitute products cost 2-3x more than their conventional equivalents. A family managing a child's peanut and tree-nut allergy spends an estimated $4,184 more per year on food alone, according to a study published in the Annals of Allergy, Asthma & Immunology. This disproportionately affects low-income families, who may be forced to take risks with ambiguously labeled products because they cannot afford the "safe" alternatives. This problem persists because the FDA has been working on precautionary labeling regulations since 2008 but has not finalized any rules. The food industry lobbies against mandatory thresholds because establishing a legally binding "safe" level of allergen contamination creates liability exposure. If a threshold is set at 10 ppm for peanut protein and a product tests at 11 ppm, the manufacturer faces recalls and lawsuits. Without a threshold, "may contain" is a legal shield, not a consumer safety tool. The structural root cause is a regulatory framework designed around ingredient disclosure (FALCPA 2004, FASTER Act 2021) but silent on contamination risk. Until the FDA establishes evidence-based action levels for allergen cross-contact — as Australia and the EU have begun to do — American consumers are left interpreting warnings that may mean everything or nothing.